Alerts will be sent to your verified email
Verify Email
MEDICAMEQ
|
Medicamen Biotech
|
Albert David
|
Brooks Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
8.49 % | 11.47 % | -23.88 % |
|
5yr average Equity Multiplier
|
1.47 | 1.63 | 1.78 |
|
5yr Average Asset Turnover Ratio
|
0.58 | 0.62 | 0.6 |
|
5yr Avg Net Profit Margin
|
10.0 % | 11.31 % | -23.79 % |
|
Price to Book
|
2.13 | 1.17 | 4.44 |
|
P/E
|
47.66 | 72.72 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
13.14 Days | -77.77 Days | -10.34 Days |
|
Inventory Days
|
66.66 Days | 47.91 Days | 93.5 Days |
|
Days Receivable
|
122.66 Days | 27.87 Days | 66.75 Days |
|
Days Payable
|
257.34 Days | 140.35 Days | 179.8 Days |
|
5yr Average Interest Coverage Ratio
|
10.36 | 93.73 | -11.84 |
|
5yr Avg ROCE
|
12.12 % | 14.69 % | -15.03 % |
|
5yr Avg Operating Profit Margin
|
16.84 % | 9.55 % | -13.23 % |
|
5 yr average Debt to Equity
|
0.14 | 0.02 | 0.21 |
|
5yr CAGR Net Profit
|
-6.51 % | -4.92 % | 0.22 % |
|
5yr Average Return on Assets
|
5.75 % | 7.03 % | -14.62 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
40.46 % | 62.24 % | 52.62 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-3.14 % | 0.25 % | -13.79 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 9.9 % |
|
Medicamen Biotech
|
Albert David
|
Brooks Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|